The Market Access Summit brought together leaders, policy experts, and industry innovators from across the healthcare landscape in Toronto this year. Don’t miss out next time—mark your calendars for 2026 and:
- Navigate HTA and reimbursement frameworks across provinces.
- Craft effective stakeholder engagement
- Harness real-world evidence to drive access and funding decisions.
- Leverage data and analytics to inform market access planning.
- Align policy, pricing, and innovation to ensure sustainable access for patients.
This year, we welcomed notable organizations, including Canada’s Drug Agency (CDA-AMC), Gilead Sciences, Sandoz Canada, the PMPRB, AbbVie, the pCPA, and many more!











